<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03161743</url>
  </required_header>
  <id_info>
    <org_study_id>PRP Platelet Yield</org_study_id>
    <nct_id>NCT03161743</nct_id>
  </id_info>
  <brief_title>Calculation of Platelet-rich Plasma Preparation Yield</brief_title>
  <official_title>Calculation of Platelet-rich Plasma Preparation Yield From Baseline CBC Platelet Count</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Harrison, Theodore, M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Harrison, Theodore, M.D.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a study to determine 1) the consistency of platelet-rich plasma produced by several&#xD;
      methods, and 2) whether the platelet content of platelet-rich plasma can be accurately&#xD;
      estimated from a baseline CBC platelet count.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the first phase of this study a baseline CBC platelet count will be performed on each&#xD;
      subject and then platelet-rich plasma (PRP) prepared from the same blood sample by six&#xD;
      different methods. The platelet count will be measured in each PRP preparation and compared&#xD;
      to the CBC platelet count to determine the platelet yield for each method.&#xD;
&#xD;
      In the second phase of the study a baseline CBC platelet count will be performed on each&#xD;
      subject and then platelet-rich plasma (PRP) prepared from the same blood sample by six&#xD;
      different methods. The CBC platelet count will be used to calculate the estimated platelet&#xD;
      content of each sample/method based on the platelet yields determined in the first phase. The&#xD;
      platelet count will be measured in each PRP preparation and compared to the estimated&#xD;
      platelet content to determine the predictive accuracy for each method.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date type="Actual">June 30, 2017</start_date>
  <completion_date type="Anticipated">May 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Platelet yield</measure>
    <time_frame>within 8 hours of blood draw</time_frame>
    <description>the number of platelets in a PRP sample as a percentage of the number of platelets in the blood from which the PRP was prepared.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Platelet yield estimate accuracy</measure>
    <time_frame>within one month of final data collection</time_frame>
    <description>standard deviation of the difference between the estimated platelet yield and the actual platelet yield.</description>
  </primary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Platelet-rich Plasma Production</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>venipuncture</intervention_name>
    <description>blood draw for the purpose of determining the platelet concentration in PRP</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        normal adults&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  English speaking&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  platelet count &lt; 150,000&#xD;
&#xD;
          -  platelet count &gt; 350,000&#xD;
&#xD;
          -  History of blood disorder&#xD;
&#xD;
          -  History of altered platelet function&#xD;
&#xD;
          -  History of chemotherapy or radiation therapy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Theodore E Harrison</last_name>
    <role>Principal Investigator</role>
    <affiliation>Theodore Harrison</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Theodore E Harrison</name>
      <address>
        <city>Sidney</city>
        <state>British Columbia</state>
        <zip>V8L5K1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <study_first_submitted>May 18, 2017</study_first_submitted>
  <study_first_submitted_qc>May 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 22, 2017</study_first_posted>
  <last_update_submitted>August 8, 2017</last_update_submitted>
  <last_update_submitted_qc>August 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Harrison, Theodore, M.D.</investigator_affiliation>
    <investigator_full_name>Theodore Harrison, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>platelet-rich plasma</keyword>
  <keyword>platelet</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

